You need
high-quality genomic data.
We know how to produce it.
The LSMC platform leverages the most advanced combination of long- and short-read sequencing technologies to produce the highest-quality raw sequence data at the best cost.
Built-in clinical confirmation
Clinical standards require confirming reported variants using orthogonal technologies. By using a hybrid long- and short-read approach, LSMC offers built-in confirmation, eliminating costly auxiliary assays and extended turnaround times.
Adding long-read sequencing delivers 20% greater diagnostic yield with every sample, thanks to significantly richer data:
Difficult regions
Coverage of previously difficult or inaccessible regions of the genomeStructural variants
Short-reads alone miss large rearrangementsMethylation
Long-reads reveal more than just the four bases of DNA. Direct methylation allows a deeper layer of biological understanding and assay development to be built on our platform.
Designed for clinical delivery
LSMC was purpose-built to support clinical diagnostics companies and large aggregators by a team accustomed to operations processing millions of samples per year. Using advanced automation and hard-won experience, the LSMC knows how to overcome the challenges and ensure you get the data you need, when you need it.